Nano-immunotherapy developed to improve lung cancer treatment
Investigators have created a ‘dual action’ treatment that combines immunotherapy with targeted drug delivery and shows promise in preclinical models of lung cancer.
Researchers discover role of Pd-1 in driving growth of merkel cell carcinoma
Our investigators recently reported research that has crucial implications for the potential development of new combination therapies for Merkel cell carcinoma.
How immunotherapy may change treatment for head and neck cancer patients
Our investigators are conducting clinical trials to answer probing questions on possible applications of immunotherapy in cancer care.